$EIKN 4 SEC Filings

Filed On	Filing
08 Sep 2026	Form 4: Column Group Iv GP, Lp, 10% owner and 7 others Bought 89,200 shares ($1.03M)
04 Mar 2026	Form 4: Klobuchar Michael A, Chief Operating Officer Granted 87,157 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Huffines Robert Luther, Director Granted 25,873 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Frazier Kenneth C, Director Granted 25,873 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Perlmutter Roger M, Director Granted 268,176 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Thorner Benjamin Bruno, See Remarks Granted 67,044 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Baynes Roy D., Chief Medical Officer Granted 134,088 Stock Option (Right to Buy)
04 Mar 2026	Form 4: Bowie Alfred Lloyd Jr., Chief Financial Officer Granted 67,044 Stock Option (Right to Buy)
10 Feb 2026	Form 4: Perlmutter Roger M, Director Received 284,857 shares by conversion
09 Feb 2026	Form 4: Column Group Iv GP, Lp, 10% owner and 7 others Received 3,595,340 shares by conversion · Bought 2,117,760 shares ($38.1M)
06 Feb 2026	Form 4: Foresite Capital Management IV, Llc, 10% owner and 7 others Received 4,041,687 shares by conversion · Bought 55,555 shares ($1M)
06 Feb 2026	Form 4: Frazier Kenneth C, Director Bought 111,111 shares ($2M)
06 Feb 2026	Form 4: Wolfe Josh, Director Bought 277,776 shares ($5M) · Received 5,695,010 shares by conversion
06 Feb 2026	Form 4: Lux Venture Partners V, Llc, 10% owner and 5 others Bought 277,776 shares ($5M) · Received 5,695,010 shares by conversion

Comments